Henrietta Lacks and the HeLa cells (Video)
Written guide: Henrietta Lacks and HeLa Cells: The Story and the Science
Cells taken from Henrietta Lacks in 1951 without her consent became the HeLa line still used in labs worldwide.
Chapters
- 0:00 Full video
Video transcript
0:00 Full video
Scientists around the world still use cells taken from one woman in 1951 without her knowledge or consent. Her name was Henrietta Lacks, and her family did not find out for more than twenty years. Henrietta Lacks was a 30-year-old African American woman with five children when she was diagnosed with an aggressive cervical cancer at Johns Hopkins Hospital in Baltimore. Doctors took samples of her cancer cells while they diagnosed and treated the disease. They gave some of that tissue to a researcher without asking her. This was common practice at the time, and US rules requiring consent were decades away. The researcher was George Gey, and in his laboratory her cells kept growing. They became the first human cancer-cell line, cells that could grow endlessly in culture. It was named HeLa, from the first two letters of her first and last names. She died of the cancer in 1951, aged 31, and she was buried in an unmarked grave. Her cells kept dividing in laboratories. Those cells soon mattered for polio. To test the polio vaccine, researchers needed a way to measure antibodies, and there were not enough monkey cells to go around. HeLa cells grew fast and were easily infected by poliovirus. A HeLa cell factory was set up at the Tuskegee Institute, directed by Russell W. Brown with James H. M. Henderson, both Black scientists. The team filled more than the 10,000 glass tubes needed in a week. HeLa cells were used to test how people responded to the vaccine, not to make the vaccine. The field trial began in April 1954. The cells also carried a clue about her cancer. In 1984, researchers found DNA of human papillomavirus type 18 in HeLa cells. Her family learned that her cells were still in use only in the 1970s. In 1973, Johns Hopkins researchers asked her relatives for blood samples. In 2013, a German team published the HeLa genome in open databases. This broke no rule, but it upset the family, because the data could reveal information about her descendants. The National Institutes of Health met the family three times, and under the agreement two family members now sit on the group that reviews access to the data. The family has also gone to court. They sued Thermo Fisher Scientific in 2021 and settled in 2023. In 2026, AP reported that Novartis had settled a similar lawsuit by her estate. In 2020, a Nature editorial said that consent for using a patient's cells in research is still not always required in the United States.